Crucially, XDR + DM patients displayed distinct immunometabolic dysregulation, characterized by elevated inflammatory markers (CRP) and a disrupted CD4+ /CD8+ T-cell balance (increased CD4+, decreased CD8+ counts). The gene discussed is CD4; the disease is diabetes mellitus.